文献
J-GLOBAL ID:201702239986893461
整理番号:17A1802363
再発性あるいは難治性末梢性T細胞リンパ腫を持つ日本人患者におけるロミデプシン:第I/II相および薬物動態試験
Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study
著者 (23件):
MARUYAMA Dai
(National Cancer Center Hospital, Tokyo, JPN)
,
TOBINAI Kensei
(National Cancer Center Hospital, Tokyo, JPN)
,
OGURA Michinori
(Tokai Central Hospital, Gifu, JPN)
,
OGURA Michinori
(Nagoya Daini Red Cross Hospital, Aichi, JPN)
,
UCHIDA Toshiki
(Nagoya Daini Red Cross Hospital, Aichi, JPN)
,
HATAKE Kiyohiko
(Cancer Inst. Hospital of Japanese Foundation for Cancer Res., Tokyo, JPN)
,
TANIWAKI Masafumi
(Kyoto Prefectural Univ. Medicine, Kyoto, JPN)
,
ANDO Kiyoshi
(Tokai Univ. School of Medicine, Kanagawa, JPN)
,
TSUKASAKI Kunihiro
(National Cancer Center Hospital East, Chiba, JPN)
,
ISHIDA Takashi
(Nagoya City Univ. Graduate School of Medical Sci., Aichi, JPN)
,
KOBAYASHI Naoki
(Sapporo Hokuyu Hospital, Hokkaido, JPN)
,
ISHIZAWA Kenichi
(Tohoku Univ. Hospital, Miyagi, JPN)
,
ISHIZAWA Kenichi
(Yamagata Univ. Fac. of Medicine, Yamagata, JPN)
,
TATSUMI Yoichi
(Kinki Univ. Hospital, Fac. of Medicine, Osaka, JPN)
,
KATO Koji
(Kyushu Univ. Hospital, Fukuoka, JPN)
,
KIGUCHI Toru
(Chugoku Central Hospital, Hiroshima, JPN)
,
IKEZOE Takayuki
(Kochi Medical School Hospital, Kochi, JPN)
,
IKEZOE Takayuki
(Fukushima Medical Univ. School of Medicine, Fukushima, JPN)
,
LAILLE Eric
(Celgene Corp., NJ, USA)
,
RO Tokihiro
(Celgene K.K., Tokyo, JPN)
,
TAMAKOSHI Hiromi
(Celgene K.K., Tokyo, JPN)
,
SAKURAI Sanae
(Celgene K.K., Tokyo, JPN)
,
OHTSU Tomoko
(Celgene K.K., Tokyo, JPN)
資料名:
International Journal of Hematology
(International Journal of Hematology)
巻:
106
号:
5
ページ:
655-665
発行年:
2017年11月
JST資料番号:
F0888A
ISSN:
0925-5710
CODEN:
IJHEEY
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)